Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
How biotechnology solves food problems
Biological concepts of genetically modified animals
A brief essay on transgenic animals
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: How biotechnology solves food problems
Genetically modified animals are an important category of the genetically modified organisms (EFSA, 2012). From EFSA and Paul Arnold (2013), genetic engineering of an animal involves manipulating or modifying the genetic code of the targeted animal to alter their original characteristics and introduce certain desired traits to the animal by adding to, substituting with or removing from genes of interest in a way that does not occur naturally (EFSA, 2012; Arnold, 2013). The genes of interest can be derived from another animal of the same species, an animal of another species, or even an organism of another kingdom (Arnold, 2013). Through the breakthroughs of genetic engineering techniques such as the recombinant DNA, genetic cloning, analysis of genes expressions and genomic mapping, scientists are able to produce the LMOs especially animals with better quality traits (Margawati, 2003).
The first genetically modified animal was produced by Rudolf Jaenisch and Beatrice Mintz in 1974 during the investigation process of the mechanism of vertical transmission of tumour virus and the possible activation during later life by injecting the Simian virus 40 DNA into mouse embryos then implanting the embryos in female mice (Jaenisch & Mintz, 1974).Later, the scientists had developed techniques which responsible for transgenic mice, rats, rabbits, sheep, and pigs in the early 1980s, and also established many of the first transgenic models of human disease. To date, the scientists proposed that there are three basic methods that are commonly used to produce the LMOs which are DNA microinjection, retrovirus-mediated gene transfer and embryonic stem cell-mediated gene transfer (Margawati, 2003). The LMOs produced contribute greatly in the huma...
... middle of paper ...
...earn.genetics.utah.edu/content/science/pharming/
University of Waikato (2011). Xenotransplantation. Retrieved March 23, 2014 from http://www.biotechlearn.org.nz/themes/xenotransplantation_and_organ_donation/xenotransplantation.
Vilotte, J-L. (2002). Lowering the milk lactose content in vivo: Potential interests, strategies and physiological consequences. Reproduction Nutrition Development, 42, 127-132.
Wheeler, M. B. (2013). Transgenic Animals in Agriculture. Nature Education Knowledge, 4(11).
Whitelaw, C. B. A., & Sang, H. M. (2005). Disease-resistant genetically modified animals. Revue scientifique et technique de l`office international des epizooties, 24(1), 275-283.
Yamanouci, K. (2005). Regulatory considerations in the development and application of biotechnology in Japan. Revue scientifique et technique de l`office international des epizooties, 24(1), 109-115.
Lactose intolerance (LI) is the inability of some humans to digest the lactose sugar contained in most dairy products and foods made with dairy products. LI has numerous readily apparent physical symptoms such as gas, cramps and diarrhea (Houts 110). More importantly, LI may lead to malnutrition in those people affected because of the loss of milk's important nutrients. Not everyone is affected by LI. In fact, genetic background rather than any other health or cultural factor seems to best predict LI. The inability of humans to digest lactose has enormous health consequences, particularly among the poor populations of the U.S. and the developing third-world countries.
Despite being magical of gene therapy, it is high-risk. Few people got benefits from it, and it has a low rate of success. Prior to the human trial, Batshaw and Wilson had done experiment on animals to ensure the safety. Over 20 experiments have been done on mice but only 12 of them survived at last (Sophia, M. and Kolehmainen, J.D., 2000). More seriously, complicating diseases, which can be more dangerous than genetic diseases, might set in during the treatment period. In December 200...
Kraemer, Duane C. “Genetically Altered Animals Will Benefit Humankind.” Genetic Engineering: Opposing Viewpoints. Ed. Carol Wekesser. San Diego: Greenhaven Press,
The intention of researchers to modify the genes of animals is to understand a wide range of medical questions. Although their purpose in using genetic engineering is to gain more knowledge that can possibly benefit the human race, they still need to give moral consideration to the animals they utilize. The reason for this is because animals are able to experience pain and discomfort. Until researchers have full capacity in knowing the outcome of the gene alteration they do on animals, then there must be regulations enforced because in the end, animals and humans share the same interest in avoiding pain and
Spearmann thought of cloning as a way to study cell differentiation. Briggs and King used the technique of nuclear transfer on amphibians and it was successful (Campbell). “Subsequently John Gurdon demonstrated the potential to reprogram differentiated cells by producing adult Xenopus using epithelial cells from developing tadpole intestine as nuclear donors,” says Alberio Campbell. Unfortunately, later studies show that this method of cloning tadpoles didn’t allow them to develop to the adult stage of life (Campbell). “The use of enucleated metaphase II oocytes as recipient cytoplasts proved more successful and in 1986 resulted in the production of live lambs using blastomeres from 8 to 16-cell stage embryos as nuclear donors,” says Campbell. This success in sheep was also used on other mammals such as cattle and swine. There were limitations to the technology. First, the “frequency development was very low”...
Yoon, Carol and Petersen, Melody, "Cautious Support On Biotech Foods by Science Panel," New York Times April 6, 2000, p. 1, A20
One’s behavior, health, disorder, and characteristics, all depend on he’s genetic code. Genetic engineering, also known has genetic modification, can have various methods, but commonly consists of alternating the DNA in an organism’s genome (Winter). Several instances of alternating the DNA in an organism comprises of changing one base pair of the organism’s DNA, removing a region of the DNA, and gene cloning (Winter). Scientist use genetic engineering to enhance and modify the characteristics of an organism (Knapton). For example, aside from the experimental purposes, the cross between Bison and beef combined each of their best quality to make one enhanced outcome. Due to the cross, the Beefalo has increased efficiency and taste, meaning they can input costs and improve profits. Other examples of genetic engineering include GMO (Genetically Modified Organism) foods, such as fruits and vegetables. Genetic engineering, although used on animals and food for decades, only recently surfaced with concrete evidence towards working on human DNA. This groundbreaking knowledge can provide new medical advances, completely altering the emblematic
the genetic modification, etc., of animals is good insofar as it is instrumentally good for humans; the proposal discusses how these practices might benefit us through the uses we make of animals, like food and medical experimentation.
Pohlmeier, B., & Eenennaam, A. V. (2008). Biomedical applications of genetically engineered and cloned animals. Retrieved from http://animalscience.ucdavis.edu/animalbiotech/Outreach/Biomedical_applications_genetically_engineered_animals.pdf
Webber, G. D. Regulation of Genetically Engineered Organisms and Products. Office of Biotechnology | Iowa State University Office of Biotechnology. Retrieved September 22, 2013, from http://www.biotech.iastate.edu/biotech_info_series/bio11.html - anchor96278
Diskin, M. G. (201). Fertility in the High Producing Dairy Cow (Vol. Volume 2). BSAS.
Breast milk is made for the baby having just the right amount of protein, sugar, water, and fat that is needed for a baby’s growth and development. As breast milk is easier for newborn’s to digest than formal, it prevents intestinal upsets. Furthermore, breast milk includes substances such as immunoglobulin’s...
Human genetic engineering has the capability to transmit usually fatal diseases. Although transmission is highly unlikely, it is one of the risk factors scientists have taken into great consideration. If animal cells or organs are transplanted into humans, zoonotic diseases may be spread. Bovine Spongiform Encephalopathy, Porcine Endogenous Retroviruses, and Nipah Encephalitis are all potentially fatal zoonotic diseases that could be transferred (Glenn). According to Linda MacDonald Glenn, J.D., L.L.M., “The introduction of these diseases to the human population could have devastating consequences” (Glenn). Human genetic engineering may also cause the production of unwanted mutations such as developmental issues. The procedures that would be used for genetically modifying human cells would include numerous alterations to sperm, eggs, stem cells, or embryos before entering a woman’s uterus. This could potentially modify the growth and development of the fetus in ways that have not yet b...
Scientists have been changing genomes of plants and animals by integrating new genes from a different species through genetic engineering, creating a genetically modified organism (GMO). Consumers in America have been eating GMOs since 1996, when they went on the market. There are benefits to genetically modifying crop plants, as it improves the crop quality and increases yield, affecting the economy and developing countries. But there are also negative effects from GMOs. Consumption of GMOs has various health effects on both body systems of animals and humans. GMOs also affect the environment, ecosystems and other animal species. The cons outweigh the pros in the case of GMOs.
In the end, gene therapy in humans needs to come a long way before it will be widely accepted, but there is great potential in the technology and it needs to be pursued. Bibliography Anderson, W. F. (1992). The Species of the World. Human Gene Therapy -. Science, 256 (5058), 808-813.